Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy (mylehaplo)

This study has been completed.
Sponsor:
Collaborators:
Otsuka Pharmaceutical Co., Ltd.
National Center for Research Resources (NCRR)
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00796562
First received: November 20, 2008
Last updated: December 8, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2016
  Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)